We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+8.35%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$116B
AUM Growth
+$12.3B
Cap. Flow
-$2.57B
Cap. Flow %
-2.21%
Top 10 Hldgs %
9.91%
Holding
5,208
New
1,193
Increased
1,491
Reduced
1,580
Closed
489

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$672M
2
MRK icon
Merck
MRK
+$476M
3
META icon
Meta Platforms (Facebook)
META
+$392M
4
MCD icon
McDonald's
MCD
+$372M
5
WFC icon
Wells Fargo
WFC
+$357M

Sector Composition

Rank Sector Weight
1 Technology 15.62%
2 Consumer Discretionary 9.84%
3 Healthcare 7.45%
4 Communication Services 7.19%
5 Financials 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAN
4001
DELISTED
The Aaron's Company Inc
AAN
$370K ﹤0.01%
11,573
-4,139
-26% -$130K
PCG icon
4002
CALL
PG&E
PCG
$47.8B
$369K ﹤0.01%
36,300
-82,500
-69% -$885K
IRAA
4003
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
$369K ﹤0.01%
+37,892
New +$375K
AAIC
4004
DELISTED
Arlington Asset Investment Corp.
AAIC
$369K ﹤0.01%
90,841
+64,030
+239% +$260K
WPG
4005
DELISTED
Washington Prime Group Inc.
WPG
$369K ﹤0.01%
+170,069
New +$446K
HLIO icon
4006
Helios Technologies
HLIO
$2.64B
$368K ﹤0.01%
4,713
+1,776
+60% +$130K
SXC icon
4007
SunCoke Energy
SXC
$757M
$367K ﹤0.01%
51,387
-141,027
-73% -$1M
OCDX
4008
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$367K ﹤0.01%
+17,150
New +$349K
BKR icon
4009
Baker Hughes
BKR
$56.8B
$366K ﹤0.01%
+16,014
New +$370K
DCPH
4010
CALL
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$366K ﹤0.01%
10,000
AVD icon
4011
American Vanguard Corp
AVD
$73.5M
$365K ﹤0.01%
+20,865
New +$396K
TCOM icon
4012
CALL
Trip.com Group
TCOM
$27.5B
$365K ﹤0.01%
10,300
-39,600
-79% -$1.51M
SLAM
4013
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$364K ﹤0.01%
+37,546
New +$366K
CLNE icon
4014
Clean Energy Fuels
CLNE
$447M
$362K ﹤0.01%
35,675
-41,517
-54% -$428K
SB icon
4015
Safe Bulkers
SB
$781M
$362K ﹤0.01%
90,223
-91,078
-50% -$319K
RAD
4016
DELISTED
Rite Aid Corporation
RAD
$362K ﹤0.01%
+22,197
New +$425K
ATIP.WS
4017
DELISTED
ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
ATIP.WS
$362K ﹤0.01%
+159,560
New +$359K
WIRE
4018
DELISTED
Encore Wire Corp
WIRE
$361K ﹤0.01%
4,768
-8,110
-63% -$624K
JOAN
4019
DELISTED
JOANN, Inc. Common Stock
JOAN
$361K ﹤0.01%
+22,952
New +$314K
SAR icon
4020
Saratoga Investment
SAR
$309M
$360K ﹤0.01%
13,405
-9,233
-41% -$236K
SIGA icon
4021
SIGA Technologies
SIGA
$223M
$359K ﹤0.01%
57,158
+38,013
+199% +$261K
EGAN icon
4022
eGain
EGAN
$176M
$358K ﹤0.01%
+31,144
New +$318K
IAG icon
4023
IAMGOLD
IAG
$8.47B
$357K ﹤0.01%
121,201
-307,531
-72% -$1.04M
CMCT
4024
Creative Media & Community Trust
CMCT
$8.25M
$356K ﹤0.01%
+2
New +$536K
SLS icon
4025
SELLAS Life Sciences
SLS
$2.23B
$356K ﹤0.01%
+32,114
New +$313K

Similar funds

D.E. Shaw & Co's Q2 2021 Portfolio in Review

As of Q2 2021, D.E. Shaw & Co held 5,208 positions worth $116B, up 12% from $104B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

D.E. Shaw & Co's Q2 2021 filing shows 1,193 new, 1,491 increased, 1,580 reduced and 489 closed positions. Its largest new stake was Weatherford International: 4,894,906 shares worth $89.1M. The largest sale was Microsoft, an estimated $672M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • D.E. Shaw & Co's largest Q2 2021 buy was Weatherford International: 4,894,906 shares worth $89.1M.
  • D.E. Shaw & Co added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $700M increase.
  • D.E. Shaw & Co's biggest Q2 2021 reduction was Microsoft, cutting an estimated $672M.
  • D.E. Shaw & Co fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $131M.
  • D.E. Shaw & Co's ten largest holdings make up 9.9% of its $116B portfolio in Q2 2021.
  • D.E. Shaw & Co opened 1,193 new positions and closed 489 in Q2 2021.
  • D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $116B.

Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.